Factors That Can Influence Autoimmune Disease Activity

Stress is among the most studied environmental factors in autoimmune research. When the body perceives a threat, the hypothalamic-pituitary-adrenal (HPA) axis releases cortisol and other stress hormones that interact directly with immune cells. While short-term stress can suppress certain immune functions, chronic stress appears to dysregulate immune tolerance — the mechanism that normally prevents the immune system from attacking the body's own tissue.

Multiple studies across conditions including rheumatoid arthritis, lupus, and multiple sclerosis have found associations between high perceived stress and increased disease activity or flare frequency. The relationship is bidirectional: chronic illness itself is a significant stressor, which can create reinforcing cycles. Stress-reduction strategies such as structured relaxation, cognitive behavioral approaches, and social support are commonly recommended as adjuncts to medical treatment — not replacements.

Viral and bacterial infections can transiently amplify immune system activity in ways that are particularly relevant to autoimmune conditions. Two mechanisms are frequently cited: molecular mimicry, where microbial proteins structurally resemble the body's own tissue, prompting cross-reactive immune responses; and bystander activation, where inflammation generated during an infection non-specifically activates self-reactive immune cells.

Respiratory viruses, including influenza and others, have been associated with flares in conditions such as lupus and inflammatory arthritis. This is one reason why clinicians managing autoimmune patients often recommend standard vaccinations — to reduce infection risk and, by extension, potential immune disruption. Vaccination decisions should always be made with a treating physician, as some immunomodulating medications may affect vaccine safety or effectiveness. See our article on how chronic inflammation connects to autoimmune conditions for more context.

The significant sex disparity in autoimmune prevalence — with conditions like lupus and Sjögren's syndrome affecting women far more frequently than men — points to a meaningful role for sex hormones. Estrogen, in particular, appears to promote certain immune pathways associated with autoimmunity, while androgens such as testosterone may have more suppressive effects on immune activation.

Clinically, many women report changes in disease activity during menstrual cycles, pregnancy, postpartum periods, and menopause. Pregnancy, for example, is associated with remission in rheumatoid arthritis for some patients — thought to involve immune tolerance shifts that protect the fetus — while postpartum periods often bring flares. These patterns are not universal, and hormonal contraception or hormone therapy decisions require individualized guidance from a specialist familiar with the specific autoimmune condition involved.

Sleep is not passive recovery time. During deep sleep, the body regulates pro-inflammatory cytokines — signaling proteins that coordinate immune responses. Chronic poor sleep is associated with elevated baseline inflammation markers such as C-reactive protein and interleukin-6, which are also implicated in autoimmune disease activity.

Research in populations with conditions including fibromyalgia, lupus, and inflammatory bowel disease consistently identifies sleep disturbance as both a symptom and a potential driver of worsening disease. Pain itself disrupts sleep, creating another feedback loop. Sleep hygiene improvements and, where appropriate, clinical evaluation for sleep disorders such as sleep apnea are increasingly recognized as meaningful components of comprehensive autoimmune management.

For people with certain autoimmune conditions — most notably systemic lupus erythematosus (SLE) — exposure to ultraviolet (UV) radiation is a well-documented trigger of disease flares. UV light can induce apoptosis (cell death) in skin cells, releasing nuclear material that the immune system of a lupus patient may then target. This can generate systemic immune activation beyond the skin.

Photosensitivity is a recognized diagnostic criterion for lupus, reported in roughly half to two-thirds of patients depending on the study. Protective measures — including broad-spectrum sunscreen, UV-blocking clothing, and limiting midday sun exposure — are commonly recommended by rheumatologists for susceptible patients. UV sensitivity is less clearly established for other autoimmune conditions, though some patients with dermatomyositis also report photosensitive rashes.

Immunomodulating and immunosuppressive medications are cornerstone treatments for many autoimmune conditions. Interruptions in therapy — whether due to side effects, supply issues, cost barriers, or patient decision — can allow immune activity to rebound rapidly. This rebound is sometimes more pronounced than the baseline disease state that preceded treatment.

Some medications used for other health conditions can also influence autoimmune activity. Certain blood pressure medications, antibiotics, and other drugs carry documented associations with drug-induced lupus or other immune effects. Patients managing autoimmune conditions should inform all treating clinicians about their full medication list, and should not adjust, pause, or discontinue treatments without professional guidance.